drugset / Trial / NCT04064411
Efficacy & Safety of Abaloparatide-Solid Microstructured Transdermal System in Postmenopausal Women With Osteoporosis
RandomizedParallel-groupSingle-blindTreatment
Summary
A 12-month study to compare the efficacy and safety of abaloparatide-solid microstructured transdermal system (sMTS) with abaloparatide-subcutaneous (SC).
Timeline
- Start
- 2019-08-05
- Primary completion
- 2021-10-05
- Completion
- 2021-11-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Abaloparatide | Peptide | 80 ug | Subcutaneous |
| Subject | Abaloparatide | Peptide | 300 ug | Other |